NL302932A - - Google Patents

Info

Publication number
NL302932A
NL302932A NL302932DA NL302932A NL 302932 A NL302932 A NL 302932A NL 302932D A NL302932D A NL 302932DA NL 302932 A NL302932 A NL 302932A
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL302932A publication Critical patent/NL302932A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL302932D 1962-12-31 NL302932A (cg-RX-API-DMAC10.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB49140/62A GB1027746A (en) 1962-12-31 1962-12-31 17-amino-androstane and -androstene derivatives
GB220063 1963-01-17

Publications (1)

Publication Number Publication Date
NL302932A true NL302932A (cg-RX-API-DMAC10.html)

Family

ID=26237361

Family Applications (1)

Application Number Title Priority Date Filing Date
NL302932D NL302932A (cg-RX-API-DMAC10.html) 1962-12-31

Country Status (5)

Country Link
BE (1) BE642020A (cg-RX-API-DMAC10.html)
ES (1) ES294887A1 (cg-RX-API-DMAC10.html)
FR (2) FR1432523A (cg-RX-API-DMAC10.html)
GB (1) GB1027746A (cg-RX-API-DMAC10.html)
NL (1) NL302932A (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU606677B2 (en) * 1987-04-22 1991-02-14 Merrell Dow Pharmaceuticals Inc. 17 beta -(cyclopropylimino) androst-5-EN-3 beta- Ol and related compounds useful as C17-20 lyase inhibitors
US5075464A (en) * 1987-04-22 1991-12-24 Merrell Dow Pharmaceuticals Inc. 17β-(cyclopropylamino)androstene derivatives
US4954488A (en) * 1989-06-14 1990-09-04 Merrell Dow Pharmaceuticals Inc. Method of treating hyperaldosteronism using 17β-cyclopropylaminoandrostene derivatives
US4966898A (en) * 1989-08-15 1990-10-30 Merrell Dow Pharmaceuticals Inc. 4-substituted 17β-(cyclopropylamino)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors

Also Published As

Publication number Publication date
ES294887A1 (es) 1964-04-16
FR3159M (fr) 1965-03-01
BE642020A (cg-RX-API-DMAC10.html) 1964-06-30
GB1027746A (en) 1966-04-27
FR1432523A (fr) 1966-03-25

Similar Documents

Publication Publication Date Title
JPS4528280B1 (cg-RX-API-DMAC10.html)
JPS3819694B1 (cg-RX-API-DMAC10.html)
FI41265B (cg-RX-API-DMAC10.html)
BE634336A (cg-RX-API-DMAC10.html)
BE634300A (cg-RX-API-DMAC10.html)
BE633400A (cg-RX-API-DMAC10.html)
NL302932A (cg-RX-API-DMAC10.html)
BE631892A (cg-RX-API-DMAC10.html)
BE630425A (cg-RX-API-DMAC10.html)
BE630349A (cg-RX-API-DMAC10.html)
BE629993A (cg-RX-API-DMAC10.html)
BE629791A (cg-RX-API-DMAC10.html)
BE629377A (cg-RX-API-DMAC10.html)
BE629308A (cg-RX-API-DMAC10.html)
BE628276A (cg-RX-API-DMAC10.html)
BE628207A (cg-RX-API-DMAC10.html)
BE625746A (cg-RX-API-DMAC10.html)
BE624131A (cg-RX-API-DMAC10.html)
BE619187A (cg-RX-API-DMAC10.html)
BE656429A (cg-RX-API-DMAC10.html)
BE635294A (cg-RX-API-DMAC10.html)
BE630613A (cg-RX-API-DMAC10.html)
BE630577A (cg-RX-API-DMAC10.html)
BE630504A (cg-RX-API-DMAC10.html)
BE630409A (cg-RX-API-DMAC10.html)